Cynata Therapeutics Limited (AU:CYP) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cynata Therapeutics Limited has announced a new proposal to issue 250,000 ordinary fully paid securities under the code CYP, with a proposed issue date of September 2, 2024. The proposal, detailed in Appendix 3B, is pending approval by the ASX for quotation on a deferred settlement basis. This move could potentially attract investors looking for new opportunities in the biotechnology sector.
For further insights into AU:CYP stock, check out TipRanks’ Stock Analysis page.